https://www.wsj.com/articles/vitamin-shoppe-owner-franchise-group-considers-going-private-11673383894
JP Morgan Maintains Overweight on Sunrun, Lowers Price Target to $55
JP Morgan analyst Mark Strouse maintains Sunrun (NASDAQ:RUN) with a Overweight and lowers the price target from $65 to $55.